Effect of Dexmedetomidine versus Remifentanil on early recovery from anesthesia and Morphine consumption in laparoscopic sleeve gastrectomy obese patients

Not Applicable

• Conditions: o any

• Registration Number: JPRN-UMIN000040880
• Lead Sponsor: King Saud University College of Medicine Riyadh, Saudi Arabia INSTITUTIONAL REVIEW BOARD (201)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-03-26
• Study Start: 2020-06-24
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1- Uncontrolled Hypertension 2- Age below 18 and older than 60 3- Non-Obese patients (BMI< 35) 4- Heart block > Ist degree 5- Allergic to morphine, alpha-2 agonist 5- Clinically significant neurological, cardiovascular, renal hepatic disease 6- History of drug abuse or chronic opioid use

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the effect of Dexmedetomidine and Remifentanil on postoperative pain in obese patients scheduled for laparoscopic sleeve gastrectomy under general anesthesia

Secondary Outcome Measures

Name	Time	Method
To assess the effect of Dexmedetomidine and Remifentanil on postoperative quality of recovery from general anesthesia (i.e. pain, hemodynamics, sedation, agitation, shivering, postoperative nausea & vomiting, length of hospital stay) and Morphine consumption in obese patients scheduled for laparoscopic sleeve gastrectomy.